Corcept Therapeutics reported $0 in Loan Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Ani Pharmaceuticals ANIP:US $ 189.52M 20.54M
Aphria Inc APH:CN C$ 901.16M 375.72M
Ardelyx ARDX:US $ 15.13M 19.22M
Aurora Cannabis Inc ACB:CN 358.61M 49.11M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bristol Myers Squibb BMY:US $ 42503M 2002M
Canopy Growth Corp WEED:CN C$ 1.64B 33.23M
Corcept Therapeutics CORT:US $ 0M 0M
Eleven Biotherapeutics EBIO:US $ 0 0
Eli Lilly And LLY:US $ 14736.6M 1463M
Esperion Therapeutics ESPR:US $ 272.1M 404K
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Knight Therapeutics Inc GUD:CN C$ 2.89M 720K
Lannett LCI:US $ 590.68M 20.02M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 26491M 908M
Novartis NOVN:VX SF 26491M 908M
Omeros OMER:US $ 312.58M 426K
Pacira Pharmaceuticals PCRX:US $ 321.71M 4.37M
Supernus Pharmaceuticals SUPN:US $ 370.38M 14.15M
Ziopharm Oncology ZIOP:US $ 0M 0M